Cambridge, MA, United States of America

Enrique Garcia-Rivera

This inventor holds 1 USPTO granted patent. Top assignees: Dana-Farber-Cancer Institute Inc., Harvard College, The Broad Institute, Inc.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Enrique Garcia-Rivera. Retrieved from https://idiyas.com/inventor/enrique-garcia-rivera

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Enrique Garcia-Rivera

Introduction

Enrique Garcia-Rivera is a notable inventor based in Cambridge, MA, who has made significant strides in the field of cancer treatment. His work focuses on developing compounds and methods that are particularly useful in treating synovial sarcomas, a rare type of cancer. With one patent to his name, Garcia-Rivera's contributions are paving the way for advancements in medical therapies.

Latest Patents

Garcia-Rivera's most recent patent is titled "Compounds and methods for treating synovial sarcomas." This invention includes innovative compounds and methodologies that aim to improve treatment outcomes for patients suffering from this challenging form of cancer. The patent reflects his commitment to addressing critical health issues through scientific research and innovation.

Career Highlights

Throughout his career, Garcia-Rivera has been associated with prestigious institutions such as The Broad Institute, Inc. and Harvard College. His work at these renowned organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research initiatives. His dedication to advancing cancer treatment is evident in his professional journey.

Collaborations

Garcia-Rivera has had the opportunity to work alongside esteemed colleagues, including Cigall Kadoch and Micah Maetani. These collaborations have enriched his research and fostered an environment of innovation and discovery.

Conclusion

Enrique Garcia-Rivera's contributions to cancer treatment through his innovative patent demonstrate his commitment to improving patient outcomes. His work continues to inspire future advancements in medical research and therapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…